​Bob Langer-backed biotech plots $86M IPO as FDA filings loom

The eye drug developer, Kala Pharmaceuticals, is the third Massachusetts biotech to announce plans this month for an IPO.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.